Memantina Alter

Memantine Hydrochloride, the active ingredient in Memantina Alter, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients, helping to reduce excitotoxic neuronal damage and support cognitive function.

GNH USA supplies Memantina Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution across markets worldwide.

Memantina Alter is used in the management of Alzheimer’s disease, targeting glutamatergic neurotransmission. - Moderate to severe Alzheimer’s disease: improves cognition and functional abilities in affected patients. - Behavioral symptoms of Alzheimer’s disease: may reduce agitation and aggression associated with the condition. - Dementia due to Alzheimer’s disease: supports daily living activities by mitigating neuronal excitotoxicity.

Memantina Alter may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Constipation: reduced bowel movements or hard stools. - Confusion: transient disorientation or difficulty concentrating.

Serious or Rare Side Effects: - Seizures: occurrence of convulsive episodes. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hallucinations: visual or auditory perceptual disturbances. - Cardiac arrhythmias: irregular heart rhythm potentially requiring medical attention.

When prescribing Memantina Alter, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: evaluate kidney function and adjust dose if necessary. - History of seizures: monitor closely for increased seizure activity. - Concomitant NMDA agonists: avoid co‑administration due to additive CNS effects. - Elderly patients: initiate therapy at the lowest effective dose and titrate slowly. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Memantina Alter can interact with other medicines; awareness of major and moderate interactions helps optimize therapy.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism may increase neurotoxicity. - Ketamine: additive CNS depression and psychotomimetic effects. - Other NMDA antagonists: concurrent use can amplify adverse CNS events.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance risk of hypotension and electrolyte imbalance. - Anticholinergic agents: can worsen cognitive impairment. - Central nervous system depressants: may increase dizziness and sedation.